TITLE

Simvastatin reduced mortality and vascular events in diabetes mellitus

PUB. DATE
January 2004
SOURCE
ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on a study related to patients with diabetes mellitus, published in the 2003 issue of the journal "Lancet." It is a heart protection study of cholesterol-lowering with simvastatin drug in 5963 people with diabetes. The patients had a medical history of diabetes mellitus, coronary heart disease, occlusive disease of noncoronary arteries, or treated hypertension. After a run-in phase, compliant patients were allocated to simvastatin. Patients in each group were also allocated to antioxidants or placebo. Patients in the simvastatin group had fewer coronary events, strokes, revascularization procedures, and major vascular events.
ACCESSION #
12104522

 

Related Articles

  • Achieving GMS2 cholesterol targets. Mead, Mike // Update;5/6/2004, Vol. 68 Issue 8, p405 

    The article gives a practical strategy for managing cholesterol levels under the new General Medical Services (GMS) contract. A cholesterol target occurs in three clinical categories in the new GMS contract with a total of 21 points available. The new British Hypertension Society guidelines...

  • Glucose, cholesterol influence CHD risk.  // Geriatrics;Aug2004, Vol. 59 Issue 8, p46 

    Cites key research findings in the U.S. in 2004 indicating that the combination of high glucose and cholesterol levels in hypertensive patients may heighten the risk of coronary heart disease (CHD). Association between cholesterol levels and CHD risk; Risk factors for CHD; Implications on...

  • Drug therapy problems suggest need for pharmaceutical services.  // PharmacoEconomics & Outcomes News;1/26/2008, Issue 545, p7 

    The article discusses a research on drug therapy problems in ambulatory clinic settings. It references a study by D. Rao and colleagues, published in the December 2007 issue of "Pharmacy World and Science." The study identified ten of the most common indications for drug therapy in Minnesota and...

  • Insulin Sensitivity, Insulinemia, and Coronary Artery Disease. Rewers, Marian; Zaccaro, Daniel; D'agostino Jr., Ralph; Haffner, Steven; Saad, Mohammed F.; Selby, Joe V.; Bergman, Richard; Savage, Peter // Diabetes Care;Mar2004, Vol. 27 Issue 3, p781 

    The aim of this study was to evaluate whether low insulin sensitivity (S1) measured using a modified frequently sampled intravenous glucose tolerance test with minimal model analysis is associated with coronary artery disease (CAD) independent of other cardiovascular risk factors. The odds ratio...

  • Paraoksonaz-1 Enzimi ve Koroner Kalp Hastalıkları ile Ä°liÅŸkisi. Tarçin, Özlem // Marmara Medical Journal;2011, Vol. 24 Issue 1, p59 

    Serum Paraoxonase-1(PON1) level, an anti-oxidant enzyme, decreases with diseases related to coronary heart diseases (CAH) such as diabetes, hypertension, hyperlipidemia and smoking. All clinical studies which were performed in patients with CAH have shown significant low levels and activity of...

  • Reducing risk factors could eradicate CHD.  // Pulse;1/13/2003, Vol. 63 Issue 2, p16 

    Focuses on the advantages of reducing population levels of high total cholesterol, high blood pressure and smoking in preventing the development of coronary heart disease.

  • Fetal, Infant, and Childhood Growth Are Predictors of Coronary Heart Disease, Diabetes, and Hypertension in Adult Men and Women. Osmond, Clive; Barker, David J.P. // Environmental Health Perspectives Supplements;Jun2000 Supplement 3, Vol. 108, p545 

    Reviews epidemiologic studies in which the incidence of coronary heart disease, hypertension and diabetes has been related to the recorded, early growth of individuals, while considering factors in the adult lifestyle. Possible mechanisms for hypertension and diabetes; Evidence for the...

  • Impact of Obesity on Work Productivity among Individuals with Type 2 Diabetes Mellitus and Varied Levels of Cardiometabolic Risk. Stewart, Walter F.; Chapman, Richard H.; Gavin III, James R.; Fox, Kathleen M.; Grandy, Susan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA249 

    Little is known about the work impact of obesity and of diabetes. We evaluated work absence and work effectiveness among nine subgroups of individuals defined by BMI (i.e., 30+ or obese, 25-25.99 or overweight, and <25 or normal weight) and diabetes (i.e., self-reported type 2 diabetes [T2D],...

  • What is the relative cardiovascular benefit of lowering cholesterol, blood pressure, and glucose levels in patients with type 2 diabetes. Epling, John // Journal of Family Practice;Apr2002, Vol. 51 Issue 4, p306 

    BACKGROUND Type 2 diabetes is increasingly recognized as a powerful risk factor for coronary artery disease (CAD) events. In its recommendations far treating cholesterol levels, the Third Adult Treatment Panel of the National Cholesterol Education Program (NCEP) considers diabetes mellitus the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics